Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Zimmer Biomet Q3 2025 Earnings Call - Innovation Cycle Drives US Growth Amid Emerging Market Challenges
Zimmer Biomet reported a 5% organic constant currency revenue growth in Q3 2025, with a notable acceleration in the US business to 5.6%, marking the best growth since mid-2023. The company highlighted...
- Zimmer Biomet achieved 5% organic constant currency revenue growth in Q3 2025, led by 5.6% growth in the US market—the strongest US performance since mid-2023.
- Late-quarter disruptions including distributor order cancellations in Eastern Europe, Middle East, and Latin America, as well as softness in restorative therapies, negatively impacted growth by nearly 120 basis points.
- Strong product adoption in US knees with Persona Osteotide cementless knee representing nearly 30% of US total knee implants, targeting over 50% penetration by end of 2027.
- +10 more takeaways
Establishment Labs Q3 2025 Earnings Call - First Positive EBITDA Quarter Fueled by U.S. Market Momentum
Establishment Labs reported a strong Q3 2025 with a 34% revenue jump to $53.8 million, driven primarily by a booming U.S. business that surged 16% sequentially despite a traditionally slow quarter. Th...
- Establishment Labs grew global revenue by 34% in Q3 2025 to $53.8 million, including $11.9 million in the U.S.
- The company achieved its first positive adjusted EBITDA quarter at $1.2 million, beating prior expectations.
- Gross profit margin exceeded 70% (70.1%) for the first time, driven by higher margin sales in the U.S.
- +13 more takeaways
3D Systems Q3 2025 Earnings Call - Strategic Pivot Amid Revenue Decline Driven by Tariff-Induced Capex Uncertainty
3D Systems reported a challenging Q3 2025 with revenue declining 13.8% year-over-year to $91.2 million, reflecting muted capital expenditures across 3D printing OEMs amid tariff uncertainties. The com...
- Q3 2025 revenue declined 13.8% year-over-year to $91.2 million, driven by continued soft capital expenditures from customers due to tariff uncertainties.
- Company closed sales of non-core software assets Octane and 3Dexter to focus on proprietary technologies, with a modest financial impact expected in Q4.
- Aggressive cost reduction initiatives underway targeting over $50 million in annualized savings by year-end, including organizational optimization and facility consolidations extending into early 2026.
- +10 more takeaways
O-I Glass Q3 2025 Earnings Call - Profit Margins Surge Amid Volume Declines and Strategic Transformation
O-I Glass reported a robust third quarter with adjusted earnings per share of $0.48, surpassing both prior year figures and company estimates. While net sales remained stable at $1.7 billion, shipment...
- O-I Glass achieved adjusted EPS of $0.48 in Q3 2025, exceeding prior year and internal forecasts.
- Net sales held steady at $1.7 billion despite a 5% decline in shipment volumes, reflecting mixed consumer demand trends.
- Volumes decreased due to weak beer and wine categories, partially offset by growth in non-alcoholic beverages, food, and RTDs.
- +17 more takeaways
GoodRx Q3 2025 Earnings Call - Strategic Expansion of Manufacturer Solutions and Pharmacy Counter Integration
GoodRx delivered a solid Q3 2025 highlighted by a 54% year-over-year revenue growth in its manufacturer solutions segment, bolstered by new partnerships with Novo Nordisk and Amgen to provide direct-t...
- GoodRx achieved 54% year-over-year revenue growth in manufacturer solutions, driven by expanded brand partnerships and new deals.
- The company closed deals with Novo Nordisk and Amgen to offer significant cash price discounts on Ozempic, Wegovy, and Repatha, enhancing direct-to-consumer access.
- Prescription transaction revenue declined 9% due to the completed Rite Aid pharmacy closures and reduced volume with an integrated savings PBM partner.
- +13 more takeaways
LivaNova Q3 2025 Earnings Call - Strong Organic Growth and Strategic Investments Drive Margin Expansion
LivaNova reported a robust third quarter in 2025, delivering 13% organic revenue growth led by cardiopulmonary momentum and epilepsy segment advances across all regions. The company raised its full-ye...
- LivaNova achieved 13% organic revenue growth in Q3 2025, driven primarily by cardiopulmonary and epilepsy segments.
- Cardiopulmonary revenue increased 16% to $203 million, bolstered by over 20% growth in heart-lung machine (HLM) sales.
- ESSENCE heart-lung machine placements accelerated in developed markets with a commercial launch in China begun in August, expected to materially contribute in 2026.
- +13 more takeaways
Steve Madden Ltd Q3 2025 Earnings Call - Tariff Challenges Temper Growth Despite Strong Brand Momentum
Steve Madden’s third quarter 2025 results reveal a business navigating intense tariff-induced disruptions with a mix of resilience and strategic pivoting. New tariffs on Chinese imports caused wholesa...
- Q3 revenue increased 6.9% to $667.9 million, but fell 14.8% excluding Kurt Geiger acquisition.
- Wholesale revenue declined 10.7%, driven by a 19% drop excluding Kurt Geiger; tariff-related order cuts and shipment delays were key factors.
- Direct-to-consumer (DTC) revenue surged 76.6%, or 1.5% excluding Kurt Geiger, reflecting strong digital engagement.
- +13 more takeaways
Brilliant Earth Q3 2025 Earnings Call - Engagement Rings Rebound and Fine Jewelry Surges Amid Industry Headwinds
Brilliant Earth marked its 20th anniversary with strong third-quarter results, reporting a 10% year-over-year net sales increase that beat expectations. The company saw a key inflection point with eng...
- Brilliant Earth achieved 10.4% year-over-year net sales growth in Q3 2025, surpassing guidance.
- Engagement ring bookings, previously soft after a market normalization, returned to year-over-year growth signaling a bridal recovery.
- Wedding and anniversary band bookings reached their highest ever, with strong growth in men's and women's collections.
- +12 more takeaways
Triple Flag Precious Metals Q3 2025 Earnings Call - Record Cash Flows Amid Strategic Royalty Acquisitions and Strong Gold Prices
Triple Flag Precious Metals delivered a standout Q3 2025, boasting record adjusted EBITDA of $79 million driven by 27,000 gold equivalent ounces (GEOs) and an operating cash flow per share of 39 cents...
- Triple Flag achieved record adjusted EBITDA of $79 million in Q3 2025, driven by 27,000 GEOs and strong gold prices.
- Operating cash flow per share rose over 25% year-over-year, reaching 39 cents US, reflecting robust cash generation.
- The company is on track to meet or exceed the midpoint to high end of its 2025 GEO production guidance.
- +11 more takeaways
Taboola Q3 2025 Earnings Call - Realize Platform Gains Traction, Driving Confident Outlook and Share Buybacks
Taboola reported a strong Q3 2025, beating guidance across key metrics with revenues of $497 million and an adjusted EBITDA margin above 27%. The company highlighted an inflection point in its Realize...
- Taboola exceeded high-end Q3 2025 guidance with $497M revenue and $48M adjusted EBITDA, delivering strong 27% EBITDA margin.
- The AI-powered Realize platform reached an inflection point, helping advertisers achieve higher ROI and fueling growth confidence.
- Number of scaled advertisers (spending $100K+) rose 4% to 2,064, while average revenue per scaled advertiser grew 11%, key drivers for ex-TAC gross profit growth.
- +7 more takeaways